Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim Corporation
6/4/2008 10:50:38 AM
More...
|
Inspire Pharmaceuticals (ISPH) Announces Development And License Agreement With Boehringer Ingelheim Pharma GmbH & Co. KG For Intranasal Epinastine In The United States And Canada
2/21/2006 10:47:06 AM
More...
|
Boehringer Ingelheim GmbH Release: Head-To-Head Study Shows COPD Patients Achieve Significantly Better Lung Function Improvements With The Combination Of Spiriva(R) And Formoterol Than The Combination Of Salmeterol And Fluticasone Propionate
10/19/2005 5:12:17 PM
More...
|
Boehringer Ingelheim Corporation Publishes Clinical Trials Online
10/19/2005 5:09:24 PM
More...
|